New Covenant Trust Company’s Labcorp LH Stock Holding History

New Covenant Trust Company’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-80	Closed	-$17.5K	–	273
2024 Q1	$17.5K	Buy	+80	New	+$17.6K	0.02%	273

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

New Covenant Trust Company's LH Position: Q2 2024 in Review

New Covenant Trust Company sold out of Labcorp (LH) in Q2 2024, closing a stake of 80 shares — an estimated $17.5K sold.

New Covenant Trust Company first reported a position in LH in Q1 2024 and held it in 1 quarter. The position peaked at $17.5K in Q1 2024. 852 funds tracked by Wall St. Rank hold LH as of Q2 2024.

New Covenant Trust Company reported no remaining Labcorp position as of Q2 2024 after selling out during the quarter.
New Covenant Trust Company sold 80 Labcorp shares in Q2 2024, an estimated $17.5K.
New Covenant Trust Company first reported a position in Labcorp in Q1 2024 and held it in 1 quarter.
New Covenant Trust Company's Labcorp position peaked at $17.5K in Q1 2024.
852 funds tracked by Wall St. Rank held Labcorp as of Q2 2024.

Based on New Covenant Trust Company's 13F filing for Q2 2024, filed 30 Jul 2024.